- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02276469
Peer Support for Severe Mental Disorders (PEER)
January 1, 2015 updated by: Prof. Dr. Thomas Bock, Universitätsklinikum Hamburg-Eppendorf
Randomized Controlled Trial of Peer to Peer Support for People With Severe Mental Disorders: Schizophrenia, Affective Disorders and Personality Disorders in Comparison to Standard Care
The purpose of this study is to determine wether peer support is effective for the treatment of people with severe mental illness.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
A randomized controlled multi center trial is conducted, where patients receive usual care in the control group and usual care with additional peer support for 6 month in the intervention group.
Psychosocial outcome criteria are collected pre intervention, after 6 month intervention and at one year follow up.
Days till hospitalization and days spent in hospital are collected for one year before recruitment and one year after recruitment.
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- clinical diagnosis of schizophrenia, unipolar depression, bipolar disorder, personality disorder
Exclusion Criteria:
- primary clinical diagnosis of addiction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: peer support
peer support is delivered on individual basis for half a year, the frequency depends on the patients requirement, but at least 3 sessions has to occur
|
peer support is delivered by persons with a severe mental illness after the experience of recovery and after absolving a one year education to support others on their way to recovery
|
|
No Intervention: usual care
usual care was delivered to the patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Self-Efficacy at 6 month
Time Frame: 1. Baseline; 6 month follow up (post intervention); twelve month follow
|
General Self-Efficacy Scale; Self report Questionnaire; 10 Items
|
1. Baseline; 6 month follow up (post intervention); twelve month follow
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in Quality of life at 6 and 12 month
Time Frame: 1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
Self report questionnaires: Modulares System zur Lebensqualität MSLQ-R
|
1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
|
Change from Baseline in Quality of life at 6 and 12 month
Time Frame: 1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
Self report questionnaires: EuroQol-Group: EQ5D
|
1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
|
Service satisfaction after six month of intervention
Time Frame: After six month intervention
|
Self report questionnaire: Client Satisfaction Questionnaire CSQ 8
|
After six month intervention
|
|
Change from Baseline in Illness management, Coping at 6 and 12 month
Time Frame: 1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
FKV-LIS Freiburger Self report questionnaire: Fragebogen zur Krankheitsverarbeitung; examining coping strategies
|
1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
|
Change from Baseline in Psychosocial functioning at 6 and 12 month
Time Frame: 1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
Clinical observation: Global assessment of functioning DSM
|
1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
|
Change from Baseline in Severity of illness at 6 and 12 month
Time Frame: 1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
Clinical observation: Clinical global impression
|
1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
|
Change from Baseline in Illness management, Coping at 6 and 12 month
Time Frame: 1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
Self report questionnaire: Subjective sense of psychosis
|
1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month follow
|
|
Hospitalization in days of in-patient care
Time Frame: one year before, until one year past intervention
|
The days of in patient care assessed from the clinical records
|
one year before, until one year past intervention
|
|
Days to hospitalization
Time Frame: Baseline until 12 month follow up
|
Days to hospitalization after the beginning of treatment assessed from the clinical records
|
Baseline until 12 month follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Thomas Bock, Prof. Dr., University Medical Center Hamburg-Eppendorf (UKE)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.
- Schwarzer, R., & Jerusalem, M. (1995). Generalized Self-Efficacy scale. In J. Weinman, S. Wright, & M. Johnston, Measures in health psychology: A user's portfolio. Causal and control beliefs (pp. 35- 37). Windsor, England: NFER-NELSON.
- Pukrop, R. (2003). Modulares System zur Lebensqualität. In J. Schumacher, A. Klaiberg & E. Brähler (Hrsg.), Diagnostische Verfahren zu Lebensqualität und Wohlbefinden (S. 227-232). Göttingen Bern Toronto S
- National Institute of Mental Health (1976). 028 CGI. Clinical Global Impressions. In: Guy, W. (Ed.), ECDEU Assessment for psychopharmacology. Rev. Ed. Rockville, Maryland. 217-222.
- Muthny, F.A. (1989). Freiburger Fragebogen zur Krankheitsverarbeitung (FKV). Manual. Weinheim: Beltz Test GmbH.
- Sass, H., Wittchen, H.U., Zaudig, M. (2001). Diagnostisches und Statistisches Manual psychischer Störungen DSM-IV. Göttingen, Bern, Toronto, Seattle: Hogrefe Verlag für Psychologie
- Bock et al. (2010) SuSi - Fragebogen zum Subjektiven Sinn von Psychosen
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2011
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
October 9, 2014
First Submitted That Met QC Criteria
October 24, 2014
First Posted (Estimate)
October 28, 2014
Study Record Updates
Last Update Posted (Estimate)
January 5, 2015
Last Update Submitted That Met QC Criteria
January 1, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SC 0748/006
- Psychenet Teilprojekt 5 (Other Identifier: University medicalcenter hamburg-eppendorf)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bipolar Disorder
-
Vielight Inc.Not yet recruitingBipolar Disorder (BD) | Bipolar | Bipolar Disorder DepressionCanada
-
ProgenaBiomeWithdrawnBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
University of Texas Southwestern Medical CenterThe Texas Child Mental Health Care Consortium (TCMHCC)RecruitingBipolar Disorder Family Members | Bipolar Disorder (BD) | Bipolar Disorder I or II | Screening ToolUnited States
-
Xenon Pharmaceuticals Inc.RecruitingBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Xenon Pharmaceuticals Inc.Enrolling by invitationBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar II DisorderUnited States
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of California, Los AngelesUniversity of Colorado, Denver; University of Pittsburgh; University of Cincinnati and other collaboratorsRecruitingAdolescents | Bipolar Disorder (BD) | Bipolar Disorder I or II | Bipolar Disorder NOS | Bipolar Spectrum DisorderUnited States
-
Babes-Bolyai UniversityRecruitingBipolar Disorder (BD)Romania
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul; Hospital Moinhos de VentoActive, not recruitingBipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II DisorderBrazil
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompletedBipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOSUnited States
Clinical Trials on peer support
-
Samantha AnthonyHeart and Stroke Foundation of CanadaNot yet recruitingHeart Failure | Cardiomyopathies | Young Adults | Peer Support | Fontan Procedure | Mentorship | Heart Transplant Recipient | Peer Support and Chronic DiseaseCanada
-
Makerere UniversityUniversity of Bergen; Centre MurazUnknownMalnutrition | Neurologic Deficits | Poor Performance Status | Infections, Hospital | Mixed Behavior and Emotional DisorderUganda
-
Northwestern UniversityCompletedDepressionUnited States
-
University of Eastern FinlandSocial Insurance Institution, Finland; Finnish Cultural FoundationRecruiting
-
Lighthouse TrustUniversity of North Carolina, Chapel Hill; World Health Organization; Kamuzu... and other collaboratorsUnknown
-
Jinan University GuangzhouGuangzhou Sport UniversityCompletedObesity Prevention | Depression - Major Depressive Disorder | Psychological Well BeingChina
-
Universitätsklinikum Hamburg-EppendorfUniversity of UlmActive, not recruitingSevere Mental Health Condition With Indication of Hospital AdmissionGermany
-
University of CalgaryHeart and Stroke Foundation of Canada; Canadian Council of Cardiovascular NursesCompletedCardiovascular DiseaseCanada
-
Hospices Civils de LyonRecruiting
-
pınar doganCompletedChronic Kidney Disease Requiring HemodialysisTurkey